Literature DB >> 10563525

Probiotics: established effects and open questions.

A von Wright1, S Salminen.   

Abstract

Human intestinal microflora is a complex ecosystem with hundreds of bacterial species. Its metabolic functions and interactions with the host probably affect the human health and well being, but these effects are extremely difficult to study. However, for about 100 years, the idea of modifying the composition of colonic flora by consuming viable bacteria in order to improve the quality of life and to prevent and treat intestinal disorders has had some popularity. Solid clinical data have usually been lacking to support the health claims associated with these so-called probiotics. The situation, however, is rapidly changing. Competent clinical studies are accumulating, showing that specific probiotic microbes, mainly lactic acid bacteria and bifidobacteria, can alleviate or prevent diverse intestinal disorders and reduce the risk of some intestinal diseases. Some indication of the mechanisms of action can also be deduced from the data available, while rapidly developing molecular biological methods offer new tools to verify the survival of the probiotics in the gut and the subsequent adhesion to mucosae. While development of foods containing probiotic bacteria has a great potential for the food industry and can be expected to positively affect the general health of the population, safety considerations have to be taken into account while introducing new species or strains without a previous history of safe food use.

Entities:  

Mesh:

Year:  1999        PMID: 10563525

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

1.  Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectors produced by mouse peritoneal macrophages.

Authors:  L S Wang; H M Zhu; D Y Zhou; Y L Wang; W D Zhang
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Antibiotic resistance, biochemical typing, and PFGE typing of Bifidobacterium strains commonly used in probiotic health foods.

Authors:  Feili Xu; Junping Wang; Yunchang Guo; Ping Fu; Huawei Zeng; Zhigang Li; Xiaoyan Pei; Xiumei Liu; Shuo Wang
Journal:  Food Sci Biotechnol       Date:  2018-02-12       Impact factor: 2.391

3.  Gut microbiota is not modified by Randomized, Double-blind, Placebo-controlled Trial of VSL#3 in Diarrhea-predominant Irritable Bowel Syndrome.

Authors:  Sonia Michail; Harshavardhan Kenche
Journal:  Probiotics Antimicrob Proteins       Date:  2011-03       Impact factor: 4.609

4.  Lactic Acid bacteria enriched from human gastric biopsies.

Authors:  Elias Hakalehto; Terttu Vilpponen-Salmela; Kristiina Kinnunen; Atte von Wright
Journal:  ISRN Gastroenterol       Date:  2011-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.